Article
Genetic variation in the farnesoid X-receptor predicts Crohn's disease severity in female patients.
Scientific reports - 16 Jul 2020
Wilson Aze, Wang Qian, Almousa Ahmed A, Jansen Laura E, Choi Yun-Hee, Schwarz Ute I, Kim Richard B
Abstract excerpt
The farnesoid X receptor (FXR) is implicated in Crohn's disease (CD) pathogenesis. It is unclear how genetic variation in FXR impacts CD severity versus genetic variation in nuclear receptors such as pregnane X receptor (PXR) and the multi-drug resistance protein 1 (MDR1, ABCB1). To evaluate FXR-1G > T as a genomic biomarker of severity in CD and propose a plausible molecular mechanism. A retrospective study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
